DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Risperdal (Risperidone) - Abnormal Behaviour - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Abnormal Behaviour (51)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal (Risperidone) where reactions include abnormal behaviour. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 51   Next >>

Possible Risperdal side effects in 3 year old male

Reported by a consumer/non-health professional from Canada on 2012-08-27

Patient: 3 year old male

Reactions: Regressive Behaviour, Abnormal Behaviour, Fall, Aggression

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in 21 year old male

Reported by a individual with unspecified qualification from United States on 2012-08-23

Patient: 21 year old male, weighing 63.5 kg (139.7 pounds)

Reactions: Anxiety, Irritability, Off Label Use, Drug Ineffective, Drug Intolerance, Abnormal Behaviour

Drug(s) suspected as cause:
Risperdal

Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-01
    End date: 2012-01-01

Seroquel
    Administration route: Oral
    Start date: 2012-04-01
    End date: 2012-06-20

Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2012-03-01
    End date: 2012-01-01

Seroquel
    Administration route: Oral
    Start date: 2012-04-01
    End date: 2012-06-20

Other drugs received by patient: Miralax



Possible Risperdal side effects in 3 year old male

Reported by a consumer/non-health professional from Canada on 2012-08-17

Patient: 3 year old male

Reactions: Regressive Behaviour, Abnormal Behaviour, Aggression

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: male

Reactions: Abnormal Behaviour, Injury, Feeling Abnormal, Hallucination, Fall, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal

Other drugs received by patient: Unspecifed Medications



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: male

Reactions: Abnormal Behaviour, Injury, Fall, Hallucination, Feeling Abnormal, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in 3 year old male

Reported by a consumer/non-health professional from Canada on 2012-08-09

Patient: 3 year old male

Reactions: Regressive Behaviour, Abnormal Behaviour, Aggression

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Abnormal Behaviour, Hallucination, Feeling Abnormal, Fall, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in 56 year old female

Reported by a physician from Italy on 2012-08-02

Patient: 56 year old female

Reactions: Confusional State, Dyskinesia, Abnormal Behaviour, Bradykinesia, Cognitive Disorder, Amnesia, Somnolence, Dysarthria, Circadian Rhythm Sleep Disorder, Anal Sphincter Atony, Memory Impairment, Asthenia, Macule

Drug(s) suspected as cause:
Keppra
    Administration route: Oral
    Start date: 2011-08-01

Risperdal
    Dosage: total daily dose: 4 mg
    Administration route: Oral
    Start date: 2012-07-01
    End date: 2012-07-16

Risperdal
    Administration route: Oral
    Start date: 2011-08-01
    End date: 2012-07-01

Other drugs received by patient: Metoclopramide Hydrochloride; Methotrexate; Cortisone Acetate



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-27

Patient: male

Reactions: Abnormal Behaviour, Fall, Cardiac Arrest, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-27

Patient: male

Reactions: Food Aversion, Therapeutic Response Unexpected, Abnormal Behaviour, Condition Aggravated, Adverse Event

Drug(s) suspected as cause:
Risperdal

Seroquel
    Administration route: Oral



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-13

Patient: male, weighing 54.4 kg (119.7 pounds)

Reactions: Wrong Technique in Drug Usage Process, Therapeutic Response Increased, TIC, Dyskinesia, Abnormal Behaviour, Intentional Drug Misuse, Streptococcal Infection

Drug(s) suspected as cause:
Risperdal
    Dosage: splitting the 1mg tablet into threes
    Administration route: Oral
    Indication: Aggression

Risperdal
    Dosage: third of tablet once a day
    Administration route: Oral

Risperdal
    Administration route: Oral

Risperdal
    Dosage: third of tablet once a day
    Administration route: Oral
    Indication: Autism

Risperdal
    Dosage: splitting the 1mg tablet into threes
    Administration route: Oral

Risperdal
    Administration route: Oral

Other drugs received by patient: Tenex



Possible Risperdal side effects in male

Reported by a physician from United States on 2012-07-09

Patient: male, weighing 147.9 kg (325.3 pounds)

Reactions: Fatigue, Adverse Event, Abnormal Behaviour, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Indication: Product Used FOR Unknown Indication

Lithium Carbonate
    Indication: Product Used FOR Unknown Indication

Risperdal
    Dosage: 2 mg in am and 4 mg in pm
    Administration route: Oral
    End date: 1997-01-01

Risperdal
    Dosage: 2 mg in am and 4 mg in pm
    Administration route: Oral
    End date: 2012-01-01

Risperdal
    Dosage: 2 mg in am and 4 mg in pm
    Administration route: Oral
    Indication: Psychotic Behaviour
    End date: 1987-01-01

Risperidone
    Indication: Product Used FOR Unknown Indication

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-01-01

Topiramate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: male, weighing 54.4 kg (119.7 pounds)

Reactions: Therapeutic Response Increased, Wrong Technique in Drug Usage Process, TIC, Dyskinesia, Abnormal Behaviour, Intentional Drug Misuse, Streptococcal Infection

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral

Risperdal
    Dosage: splitting the 1mg tablet into threes
    Administration route: Oral

Risperdal
    Dosage: splitting the 1mg tablet into threes
    Administration route: Oral
    Indication: Aggression

Risperdal
    Dosage: third of tablet once a day
    Administration route: Oral

Risperdal
    Dosage: third of tablet once a day
    Administration route: Oral
    Indication: Autism

Other drugs received by patient: Tenex



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-29

Patient: female

Reactions: Malaise, Urinary Tract Infection, Abnormal Behaviour, Disturbance in Attention, Status Epilepticus, Disorientation, Extrapyramidal Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal



Possible Risperdal side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in 30 year old male

Reported by a physician from Germany on 2012-06-22

Patient: 30 year old male

Reactions: Confusional State, Rhabdomyolysis, Restlessness, Body Temperature Increased, Tachycardia, Abnormal Behaviour, Aggression, Irritability, Bronchitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ciatyl
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-10
    End date: 2012-01-10

Ciatyl
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-01-12

Haldol
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-12

Haldol
    Start date: 2012-01-12

Risperdal
    Administration route: Oral
    Start date: 2012-01-10
    End date: 2012-01-10

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-17

Risperdal
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-01-12

Other drugs received by patient: Diazepam; Diazepam; Diazepam



Possible Risperdal side effects in 5 year old male

Reported by a individual with unspecified qualification from United States on 2012-06-14

Patient: 5 year old male

Reactions: Constipation, Hyperhidrosis, Abdominal Pain Upper, Educational Problem, Palpitations, Chest Pain, Feeling Hot, Crying, Back Pain, Retching, Pain in Extremity, Musculoskeletal Pain, Abnormal Behaviour, Skin Disorder, DRY Skin, Aggression, Heart Rate Decreased, Pollakiuria

Drug(s) suspected as cause:
Celexa
    Dosage: once a day
    Indication: Anxiety

Risperdal
    Dosage: once a day po
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder



Possible Risperdal side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-04

Patient: male, weighing 59.0 kg (129.7 pounds)

Reactions: Psychotic Disorder, Sedation, Abnormal Behaviour, Feeling Abnormal

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-03-01
    End date: 2012-04-01

Invega
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-03-01
    End date: 2012-04-01

Lamictal
    Dosage: once at night
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-03-01

Lamictal
    Dosage: once at night
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-03-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-01-01
    End date: 2012-01-01

Risperdal
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2011-01-01
    End date: 2012-01-01



Possible Risperdal side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-23

Patient: male, weighing 59.0 kg (129.7 pounds)

Reactions: Psychotic Disorder, Sedation, Abnormal Behaviour, Feeling Abnormal

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-03-01
    End date: 2012-04-01

Invega
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-03-01
    End date: 2012-04-01

Lamictal
    Dosage: once at night
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-03-01

Lamictal
    Dosage: once at night
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-03-01

Risperdal
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2011-01-01
    End date: 2012-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-01-01
    End date: 2012-01-01



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-03

Patient: male

Reactions: Weight Increased, Drug Ineffective, Hyperphagia, Abnormal Behaviour

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2001-01-01

Risperdal
    Administration route: Oral

Risperdal
    Dosage: 4 mg+2 mg in pm
    Administration route: Oral
    Indication: Bipolar Disorder

Risperdal
    Administration route: Oral
    Start date: 2001-01-01

Risperdal
    Administration route: Oral
    Indication: Schizoaffective Disorder

Risperdal
    Dosage: 4 mg+2 mg in pm
    Administration route: Oral

Risperdal
    Dosage: 4 mg in am
    Administration route: Oral

Risperdal
    Dosage: 4 mg in am
    Administration route: Oral

Other drugs received by patient: Lithium Carbonate; Lithium Carbonate



Possible Risperdal side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-27

Patient: male

Reactions: Anxiety, Akathisia, Paranoia, Abnormal Behaviour, Ataxia, Anger, Aggression

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Start date: 2012-01-01

Risperdal Consta
    Indication: Schizophrenia



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26

Patient: male

Reactions: TIC, Abnormal Behaviour

Drug(s) suspected as cause:
Risperdal
    Dosage: 1 bid po
    Administration route: Oral
    Indication: Autism
    Start date: 2008-01-01

Risperdal
    Dosage: 1 bid po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-01-01



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in 52 year old male

Reported by a physician from France on 2012-03-30

Patient: 52 year old male

Reactions: Muscular Weakness, Abnormal Behaviour, Disorientation, Amnesia, Delirium, Erectile Dysfunction, Fatigue, Oedema Peripheral, Oedema, Depression, Hallucination, Feeling Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Risperdal
    Dosage: 8mg in 4 intakes
    Administration route: Oral
    Start date: 2011-07-01
    End date: 2011-11-01

Other drugs received by patient: Tegretol; Oxazepam; Sleeping Drug; Oxazepam; Lepticur; Solian



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017